ASM Global’s Rapidly Expanding Convention Division Unveils Exhibition World Bahrain, Middle East’s Largest Exhibition Centre
23.11.2022 04:57:00 EET | Business Wire | Press release
ASM Global, the world’s leading venue management company and producer of live experiences, has made history with the spectacular firework-laden inauguration ceremony of the 950,000-square-foot Exhibition World Bahrain—the largest exhibition centre in the Middle East.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221122005879/en/
Image courtesy of ASM Global
The Kingdom’s Exhibition World is one of the most contemporary such venues in the world. Its launch is a milestone in the Kingdom’s economic development and is expected to play a key role in advancing the economic competitiveness and positioning of Bahrain as a major global destination for regional and international conventions.
The venue joins ASM Global’s portfolio of more than 350 venues around the world and kicks off the company’s post-pandemic convention growth initiative.
ASM Global’s President and CEO Ron Bension said, “This moment is the culmination of our plan developed during the pandemic leveraging our belief that this part of the world would be the quickest to not only return to normal but move quickly to dramatically increase its convention and exhibition market share.
“We’re also looking forward to leveraging the widest network in the world within the MICE industry to create unique experiences built on years of expertise.”
The opening extravaganza was attended on behalf of His Majesty King Hamad bin Isa Al Khalifa, by His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister of Bahrain.
HRH Prince Salman bin Hamad highlighted the importance of competitiveness as a fundamental element of the kingdom’s economy, which has bolstered investments, promoted economic progress and created quality opportunities for citizens. He also noted that tourism remains a leading economic sector, adding that the sector's growth has been a key driver of the kingdom’s comprehensive development, led by His Majesty the King.
During the ceremony, Bahrain Tourism Minister H.E. Fatima Al Sairafi noted the kingdom’s longstanding history in being a destination linking the east and west for trade, which has furthered its position as a global tourist destination. She added that the inauguration of the venue reflects the kingdom’s commitment to expanding cross-sector development in line with Bahrain's sustainable development goals.
Exhibition World Bahrain is unique for its adaptable and flexible design, featuring 10 halls with a combined total of 95,000 sqm. The spectacular Grand Hall has a capacity of 4,000 seated guests and is supported by 94 meeting rooms as well as 25 F&B and retail outlets throughout the exhibition concourse. The centre’s spacious design enables it to host a number of events simultaneously, making it an attractive location for local, regional and international exhibitions, conventions, galas, weddings, concerts, sports, and live entertainment events.
Exhibition World Bahrain is owned by the Bahrain Tourism and Exhibitions Authority (BTEA), which plans to utilize ASM Global’s wider network within the MICE industry to create unique experiences built on years of expertise.
ASM Global APAC and Gulf Region Chairman and Chief Executive Harvey Lister AM congratulated BTEA on the inauguration of Exhibition World Bahrain, one of the Middle East’s largest exhibition and convention centres.
“ASM Global is proud to be working in partnership with BTEA helping to ensure Bahrain will be at the forefront of attracting tourism investment, international conventions and exhibitions and world-class live events to the Gulf region,” Lister said. “This iconic landmark venue will further position Bahrain as an international destination, helping to drive diversification of growth, benefiting the local economy and further enhancing the kingdom’s global standing.”
Exhibition World Bahrain General Manager Dr Debbie Kristiansen said she was extremely proud of her dedicated and committed team and their passion and determination to “give back” to the beautiful country of Bahrain, helping to create long-term legacies for the future. Dr Kristiansen highlighted the importance of mentoring and building the talent and skillset of young Bahrainis describing it as a “privilege.”
Following the grand opening, Exhibition World Bahrain immediately opened to the public with three concurrent events expected to see well over 100,000 visitors over the span of five days: Jewellery Arabia, the premier jewellery and watch show celebrating its 30th edition; Scent Arabia’s first-ever exhibition; and Cityscape, the region’s largest real estate summit and exhibition.
ASM Global’s network hosts 20,000 events and welcomes 165 million guests every year. Other flagship exhibition and convention centres in its portfolio include McCormick Place in Chicago; Moscone Center in San Francisco; ICC Sydney; Shenzhen World in China; and P&J Live in Aberdeen, U.K.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management—delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centres, and performing arts venues. Follow us on Facebook, Instagram, Twitter and LinkedIn. asmglobal.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221122005879/en/
Contact information
PRESS CONTACT:
Jim Yeager
jim@breakwhitelight.com (for ASM Global)
Mobile: 818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom